[1] |
WEKERLE T, SEGEV D, LECHLER R, et al. Strategies for long-term preservation of kidney graft function[J]. Lancet, 2017, 389(10084): 2152-2162. DOI: 10.1016/S0140-6736(17)31283-7.
|
[2] |
HARIHARAN S, ISRANI AK, DANOVITCH G. Long-term survival after kidney transplantation[J]. N Engl J Med, 2021, 385(8): 729-743. DOI: 10.1056/NEJMra2014530.
|
[3] |
FILIPPONE EJ, FARBER JL. The monitoring of donor-derived cell-free DNA in kidney transplantation[J]. Transplantation, 2021, 105(3): 509-516. DOI: 10.1097/TP.0000000000003393.
|
[4] |
OELLERICH M, SHERWOOD K, KEOWN P, et al. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury[J]. Nat Rev Nephrol, 2021, 17(9): 591-603. DOI: 10.1038/s41581-021-00428-0.
|
[5] |
GARG N, MANDELBROT DA, PARAJULI S, et al. The clinical value of donor-derived cell-free DNA measurements in kidney transplantation[J]. Transplant Rev (Orlando), 2021, 35(4): 100649. DOI: 10.1016/j.trre.2021.100649.
|
[6] |
GIELIS EM, BEIRNAERT C, DENDOOVEN A, et al. Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay[J]. PLoS One, 2018, 13(12): e0208207. DOI: 10.1371/journal.pone.0208207.
|
[7] |
SHEN J, ZHOU Y, CHEN Y, et al. Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study[J]. Transpl Int, 2019, 32(2): 184-192. DOI: 10.1111/tri.13341.
|
[8] |
HAN F, WAN S, SUN Q, et al. Donor plasma mitochondrial DNA is correlated with posttransplant renal allograft function[J]. Transplantation, 2019, 103(11): 2347-2358. DOI: 10.1097/TP.0000000000002598.
|
[9] |
KIM K, MOON H, LEE YH, et al. Clinical relevance of cell-free mitochondrial DNA during the early postoperative period in kidney transplant recipients[J]. Sci Rep, 2019, 9(1): 18607. DOI: 10.1038/s41598-019-54694-x.
|
[10] |
CHEN XT, CHEN WF, LI J, et al. Urine donor-derived cell-free DNA helps discriminate BK polyomavirus-associated nephropathy in kidney transplant recipients with BK polyomavirus infection[J]. Front Immunol, 2020, 11: 1763. DOI: 10.3389/fimmu.2020.01763.
|
[11] |
BLOOM RD, BROMBERG JS, POGGIO ED, et al. Cell-free DNA and active rejection in kidney allografts[J]. J Am Soc Nephrol, 2017, 28(7): 2221-2232. DOI: 10.1681/ASN.2016091034.
|
[12] |
WHITLAM JB, LING L, SKENE A, et al. Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction[J]. Am J Transplant, 2019, 19(4): 1037-1049. DOI: 10.1111/ajt.15142.
|
[13] |
OELLERICH M, SHIPKOVA M, ASENDORF T, et al. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study[J]. Am J Transplant, 2019, 19(11): 3087-3099. DOI: 10.1111/ajt.15416.
|
[14] |
BROMBERG JS, BRENNAN DC, POGGIO E, et al. Biological variation of donor-derived cell-free DNA in renal transplant recipients: clinical implications[J]. J Appl Lab Med, 2017, 2(3): 309-321. DOI: 10.1373/jalm.2016.022731.
|
[15] |
SCHÜTZ E, ASENDORF T, BECK J, et al. Time-dependent apparent increase in dd-cfDNA percentage in clinically stable patients between one and five years following kidney transplantation[J]. Clin Chem, 2020, 66(10): 1290-1299. DOI: 10.1093/clinchem/hvaa175.
|
[16] |
SIGDEL TK, ARCHILA FA, CONSTANTIN T, et al. Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR[J]. J Clin Med, 2018, 8(1): 19. DOI: 10.3390/jcm8010019.
|
[17] |
ZHANG H, ZHENG C, LI X, et al. Diagnostic performance of donor-derived plasma cell-free DNA fraction for antibody-mediated rejection in post renal transplant recipients: a prospective observational study[J]. Front Immunol, 2020, 11: 342. DOI: 10.3389/fimmu.2020.00342.
|
[18] |
HUANG E, SETHI S, PENG A, et al. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients[J]. Am J Transplant, 2019, 19(6): 1663-1670. DOI: 10.1111/ajt.15289.
|
[19] |
WIJTVLIET VPWM, PLAEKE P, ABRAMS S, et al. Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and Meta-analysis[J]. Transpl Int, 2020, 33(12): 1626-1642. DOI: 10.1111/tri.13753.
|
[20] |
XIAO H, GAO F, PANG Q, et al. Diagnostic accuracy of donor-derived cell-free DNA in renal-allograft rejection: a Meta-analysis[J]. Transplantation, 2021, 105(6): 1303-1310. DOI: 10.1097/TP.0000000000003443.
|
[21] |
STITES E, KUMAR D, OLAITAN O, et al. High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury[J]. Am J Transplant, 2020, 20(9): 2491-2498. DOI: 10.1111/ajt.15822.
|
[22] |
JORDAN SC, BUNNAPRADIST S, BROMBERG JS, et al. Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients[J]. Transplant Direct, 2018, 4(9): e379. DOI: 10.1097/TXD.0000000000000821.
|
[23] |
YANG JYC, SARWAL RD, SIGDEL TK, et al. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection[J]. Sci Transl Med, 2020, 12(535): eaba2501. DOI: 10.1126/scitranslmed.aba2501.
|
[24] |
HUMMEL EM, HESSAS E, MÜLLER S, et al. Cell-free DNA release under psychosocial and physical stress conditions[J]. Transl Psychiatry, 2018, 8(1): 236. DOI: 10.1038/s41398-018-0264-x.
|
[25] |
SHEN J, GUO L, YAN P, et al. Prognostic value of the donor-derived cell-free DNA assay in acute renal rejection therapy: a prospective cohort study[J]. Clin Transplant, 2020, 34(10): e14053. DOI: 10.1111/ctr.14053.
|
[26] |
STEGGERDA J, PHAN PIZZO H, GARRISON J, et al. Use of donor derived cell-free DNA assay to monitor treatment response to allograft rejection in pediatric renal transplant recipients[J]. Am J Transplant, 2020, 20(suppl 3): 673.
|
[27] |
KYESO Y, BHALLA A, SMITH AP, et al. Donor-derived cell-free DNA kinetics post-kidney transplant biopsy[J]. Transplant Direct, 2021, 7(6): e703. DOI: 10.1097/TXD.0000000000001149.
|
[28] |
KANT S, BROMBERG J, HAAS M, et al. Donor-derived cell-free DNA and the prediction of BK virus-associated nephropathy[J]. Transplant Direct, 2020, 6(11): e622. DOI: 10.1097/TXD.0000000000001061.
|
[29] |
HEN J, GUO L, LEI W, et al. Urinary donor-derived cell-free DNA as a non-invasive biomarker for BK polyomavirus-associated nephropathy[J]. J Zhejiang Univ Sci B, 2021, 22(11): 917-928. DOI: 10.1631/jzus.B2100131.
|
[30] |
HART A, SMITH JM, SKEANS MA, et al. OPTN/SRTR 2018 annual data report: kidney[J]. Am J Transplant, 2020, 20 (Suppl s1): 20-130. DOI: 10.1111/ajt.15672.
|
[31] |
OLAITAN OK, LOEB S, HETTERMAN E, et al. Donor-derived cell-free DNA for surveillance in simultaneous pancreas and kidney transplant recipients, can we extrapolate from kidney transplant alone[J]. Am J Transplant, 2019, 19(suppl 3): D264.
|
[32] |
AL-SAFFAR F, HSU J, FUENTES J SJ, et al. Combined allosure and allomap testing in multi-organ heart transplantation rejection surveillance[J]. J Heart Lung Transplant, 2020, 39(4): S260-S261.
|
[33] |
MCCLURE T, GOH SK, COX D, et al. Donor-specific cell-free DNA as a biomarker in liver transplantation: a review[J]. World J Transplant, 2020, 10(11): 307-319. DOI: 10.5500/wjt.v10.i11.307.
|
[34] |
蒋廷亚, 周阳, 程东瑞. 供者来源游离DNA在移植肾损伤中的研究进展[J]. 中华器官移植杂志, 2019, 40(9): 566-569. DOI: 10.3760/cma.j.issn.0254-1785.2019.09.013.JIANG TY, ZHOU Y, CHENG DR. Research progress of donor-derived cell-free DNA in renal allograft injury[J]. Chin J Organ Transplant, 2019, 40(9): 566-569. DOI: 10.3760/cma.j.issn.0254-1785.2019.09.013.
|
[35] |
HUNG EC, SHING TK, CHIM SS, et al. Presence of donor-derived DNA and cells in the urine of sex-mismatched hematopoietic stem cell transplant recipients: implication for the transrenal hypothesis[J]. Clin Chem, 2009, 55(4): 715-722. DOI: 10.1373/clinchem.2008.113530.
|
[36] |
SIGDEL TK, VITALONE MJ, TRAN TQ, et al. A rapid noninvasive assay for the detection of renal transplant injury[J]. Transplantation, 2013, 96(1): 97-101. DOI: 10.1097/TP.0b013e318295ee5a.
|
[37] |
GOH Y, HO S, RAMAN L, et al. Noninvasive renal transplant graft monitoring in single institution using cell-free DNA in recipient plasma via insertion-deletion allele polymorphism[J]. Am J Transplant, 2017, 17(suppl 3): 718.
|
[38] |
ZHANG L, HU X, YIN L, et al. Early upsurge of cell free Alu DNA predicts declining long-term graft survival[J]. Am J Transplant, 2011, 11(suppl 2): 389.
|
[39] |
YANG JYC, SARWAL RD, FERVENZA FC, et al. Noninvasive urinary monitoring of progression in IgA nephropathy[J]. Int J Mol Sci, 2019, 20(18): 4463. DOI: 10.3390/ijms20184463.
|
[40] |
QUAGLIA M, MERLOTTI G, GUGLIELMETTI G, et al. Recent advances on biomarkers of early and late kidney graft dysfunction[J]. Int J Mol Sci, 2020, 21(15): 5404. DOI: 10.3390/ijms21155404.
|
[41] |
CELEC P, VLKOVÁ B, LAUKOVÁ L, et al. Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases[J]. Expert Rev Mol Med, 2018, 20: e1. DOI: 10.1017/erm.2017.12.
|
[42] |
KNIGHT SR, THORNE A, LO FARO ML. Donor-specific cell-free DNA as a biomarker in solid organ transplantation. a systematic review[J]. Transplantation, 2019, 103(2): 273-283. DOI: 10.1097/TP.0000000000002482.
|
[43] |
MARTUSZEWSKI A, PALUSZKIEWICZ P, KRÓL M, et al. Donor-derived cell-free DNA in kidney transplantation as a potential rejection biomarker: a systematic literature review[J]. J Clin Med, 2021, 10(2): 193. DOI: 10.3390/jcm10020193.
|
[44] |
DENGU F. Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation[J]. Transplant Rev (Orlando), 2020, 34(3): 100542. DOI: 10.1016/j.trre.2020.100542.
|
[45] |
VASCO M, BENINCASA G, FIORITO C, et al. Clinical epigenetics and acute/chronic rejection in solid organ transplantation: an update[J]. Transplant Rev (Orlando), 2021, 35(2): 100609. DOI: 10.1016/j.trre.2021.100609.
|
[46] |
KANT S, BRENNAN DC. Donor-derived cell-free DNA in kidney transplantation: origins, present and a look to the future[J]. Medicina (Kaunas), 2021, 57(5): 482. DOI: 10.3390/medicina57050482.
|
[47] |
JAIKARANSINGH V, KADAMBI PV. Donor-derived cell-free DNA (ddcf-DNA) and acute antibody-mediated rejection in kidney transplantation[J]. Medicina (Kaunas), 2021, 57(5): 436. DOI: 10.3390/medicina57050436.
|
[48] |
KAMATH M, SHEKHTMAN G, GROGAN T, et al. Variability in donor-derived cell-free DNA scores to predict mortality in heart transplant recipients - a proof-of-concept study[J]. Front Immunol, 2022, 13: 825108. DOI: 10.3389/fimmu.2022.825108.
|
[49] |
SORBINI M, TOGLIATTO GM, SIMONATO E, et al. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: a single-institution pilot study[J]. J Heart Lung Transplant, 2021, 40(8): 794-804. DOI: 10.1016/j.healun.2021.05.001.
|
[50] |
NISSAISORAKARN P, PATEL H, AMTUL A, et al. Protocol-based donor-derived cell-free DNA surveillance in kidney transplant recipients: a single-center experience[J]. Clin Nephrol, 2022, DOI: 10.5414/CN110760[Epub ahead of print].
|